Discovery of novel, potent, selective, and orally active human glucagon receptor antagonists containing a pyrazole core
β Scribed by Dong-Ming Shen; Edward J. Brady; Mari R. Candelore; Qing Dallas-Yang; Victor D.-H. Ding; William P. Feeney; Guoquiang Jiang; Margaret E. McCann; Steve Mock; Sajjad A. Qureshi; Richard Saperstein; Xiaolan Shen; Xinchun Tong; Laurie M. Tota; Michael J. Wright; Xiaodong Yang; Song Zheng; Kevin T. Chapman; Bei B. Zhang; James R. Tata; Emma R. Parmee
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 461 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0960-894X
No coin nor oath required. For personal study only.
β¦ Synopsis
A novel class of 1,3,5-pyrazoles has been discovered as potent human glucagon receptor antagonists. Notably, compound 26 is orally bioavailable in several preclinical species and shows selectivity towards cardiac ion channels, other family B receptors such hGIP and hGLP1, and a large panel of enzymes and additional receptors. When dosed orally, compound 26 is efficacious in suppressing glucagon induced plasma glucose excursion in rhesus monkey and transgenic murine pharmacodynamic models at 1 and 10 mpk, respectively.
π SIMILAR VOLUMES
## Abstract For Abstract see ChemInform Abstract in Full Text.
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a βFull Textβ option. The original article is trackable v